The global syphilis immunoassay diagnostics market size is calculated at USD 611 million in 2025 and is forecasted to reach around USD 992.65 million by 2034, accelerating at a CAGR of 5.54% from 2025 to 2034. The North America market size surpassed USD 335.78 million in 2024 and is expanding at a CAGR of 5.63% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Syphilis Immunoassay Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Syphilis Immunoassay Diagnostics Market Revenue and Volume Forecast, by Test Type
8.1.1. Treponemal Tests
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Non-Treponemal Tests
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Point-of-Care Rapid Tests
8.1.3.1. Market Revenue and Volume Forecast
9.1. Syphilis Immunoassay Diagnostics Market Revenue and Volume Forecast, by Technology
9.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Chemiluminescent Immunoassays (CLIA/CIA)
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Lateral Flow Assays (LFA)
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Fluorescent Treponemal Antibody Absorption (FTA-ABS)
9.1.4.1. Market Revenue and Volume Forecast
10.1. Syphilis Immunoassay Diagnostics Market Revenue and Volume Forecast, by Sample Type
10.1.1. Blood/Serum
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Oral Fluid
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Whole Blood via Fingerstick
10.1.3.1. Market Revenue and Volume Forecast
11.1. Syphilis Immunoassay Diagnostics Market Revenue and Volume Forecast, by End-User
11.1.1. Hospitals and Specialty Clinics
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Diagnostic Laboratories
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Blood Banks
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Mobile/Community Health Centers
11.1.4.1. Market Revenue and Volume Forecast
11.1.5. Home-Based Self-Testing
11.1.5.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Test Type
12.1.2. Market Revenue and Volume Forecast, by Technology
12.1.3. Market Revenue and Volume Forecast, by Sample Type
12.1.4. Market Revenue and Volume Forecast, by End-User
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Test Type
12.1.5.2. Market Revenue and Volume Forecast, by Technology
12.1.5.3. Market Revenue and Volume Forecast, by Sample Type
12.1.5.4. Market Revenue and Volume Forecast, by End-User
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Test Type
12.1.6.2. Market Revenue and Volume Forecast, by Technology
12.1.6.3. Market Revenue and Volume Forecast, by Sample Type
12.1.6.4. Market Revenue and Volume Forecast, by End-User
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Test Type
12.2.2. Market Revenue and Volume Forecast, by Technology
12.2.3. Market Revenue and Volume Forecast, by Sample Type
12.2.4. Market Revenue and Volume Forecast, by End-User
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Test Type
12.2.5.2. Market Revenue and Volume Forecast, by Technology
12.2.5.3. Market Revenue and Volume Forecast, by Sample Type
12.2.5.4. Market Revenue and Volume Forecast, by End-User
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Test Type
12.2.6.2. Market Revenue and Volume Forecast, by Technology
12.2.6.3. Market Revenue and Volume Forecast, by Sample Type
12.2.6.4. Market Revenue and Volume Forecast, by End-User
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Test Type
12.2.7.2. Market Revenue and Volume Forecast, by Technology
12.2.7.3. Market Revenue and Volume Forecast, by Sample Type
12.2.7.4. Market Revenue and Volume Forecast, by End-User
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Test Type
12.2.8.2. Market Revenue and Volume Forecast, by Technology
12.2.8.3. Market Revenue and Volume Forecast, by Sample Type
12.2.8.4. Market Revenue and Volume Forecast, by End-User
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Test Type
12.3.2. Market Revenue and Volume Forecast, by Technology
12.3.3. Market Revenue and Volume Forecast, by Sample Type
12.3.4. Market Revenue and Volume Forecast, by End-User
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Test Type
12.3.5.2. Market Revenue and Volume Forecast, by Technology
12.3.5.3. Market Revenue and Volume Forecast, by Sample Type
12.3.5.4. Market Revenue and Volume Forecast, by End-User
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Test Type
12.3.6.2. Market Revenue and Volume Forecast, by Technology
12.3.6.3. Market Revenue and Volume Forecast, by Sample Type
12.3.6.4. Market Revenue and Volume Forecast, by End-User
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Test Type
12.3.7.2. Market Revenue and Volume Forecast, by Technology
12.3.7.3. Market Revenue and Volume Forecast, by Sample Type
12.3.7.4. Market Revenue and Volume Forecast, by End-User
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Test Type
12.3.8.2. Market Revenue and Volume Forecast, by Technology
12.3.8.3. Market Revenue and Volume Forecast, by Sample Type
12.3.8.4. Market Revenue and Volume Forecast, by End-User
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Test Type
12.4.2. Market Revenue and Volume Forecast, by Technology
12.4.3. Market Revenue and Volume Forecast, by Sample Type
12.4.4. Market Revenue and Volume Forecast, by End-User
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Test Type
12.4.5.2. Market Revenue and Volume Forecast, by Technology
12.4.5.3. Market Revenue and Volume Forecast, by Sample Type
12.4.5.4. Market Revenue and Volume Forecast, by End-User
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Test Type
12.4.6.2. Market Revenue and Volume Forecast, by Technology
12.4.6.3. Market Revenue and Volume Forecast, by Sample Type
12.4.6.4. Market Revenue and Volume Forecast, by End-User
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Test Type
12.4.7.2. Market Revenue and Volume Forecast, by Technology
12.4.7.3. Market Revenue and Volume Forecast, by Sample Type
12.4.7.4. Market Revenue and Volume Forecast, by End-User
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Test Type
12.4.8.2. Market Revenue and Volume Forecast, by Technology
12.4.8.3. Market Revenue and Volume Forecast, by Sample Type
12.4.8.4. Market Revenue and Volume Forecast, by End-User
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Test Type
12.5.2. Market Revenue and Volume Forecast, by Technology
12.5.3. Market Revenue and Volume Forecast, by Sample Type
12.5.4. Market Revenue and Volume Forecast, by End-User
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Test Type
12.5.5.2. Market Revenue and Volume Forecast, by Technology
12.5.5.3. Market Revenue and Volume Forecast, by Sample Type
12.5.5.4. Market Revenue and Volume Forecast, by End-User
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Test Type
12.5.6.2. Market Revenue and Volume Forecast, by Technology
12.5.6.3. Market Revenue and Volume Forecast, by Sample Type
12.5.6.4. Market Revenue and Volume Forecast, by End-User
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial PerTest Typeance
13.1.4. Recent Initiatives
13.2. Siemens Healthineers
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial PerTest Typeance
13.2.4. Recent Initiatives
13.3. bioMérieux
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial PerTest Typeance
13.3.4. Recent Initiatives
13.4. F. Hoffmann-La Roche AG
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial PerTest Typeance
13.4.4. Recent Initiatives
13.5. Bio-Rad Laboratories
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial PerTest Typeance
13.5.4. Recent Initiatives
13.6. Thermo Fisher Scientific
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial PerTest Typeance
13.6.4. Recent Initiatives
13.7. Zephyr Biomedicals (Trinity)
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial PerTest Typeance
13.7.4. Recent Initiatives
13.8. Omega Diagnostics
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial PerTest Typeance
13.8.4. Recent Initiatives
13.9. Chembio Diagnostics
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial PerTest Typeance
13.9.4. Recent Initiatives
13.10. Sekisui Diagnostics
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial PerTest Typeance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description